Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc.

INTS
Intensity Therapeutics, Inc.US flagNASDAQ Capital Market
4.40
USD
-0.30
- -
8.30MMarket Cap

Intensity Therapeutics, Inc. (INTS) Stock Split History

Learn about Intensity Therapeutics, Inc.'s most recent 1-for-25 basis stock split on February 19, 2026. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Intensity Therapeutics, Inc.'s most recent stock split

Split Date: 2026-02-19
Split Ratio: 1:25
Price Before Split: $0.26
Price After Split: $0.01

Developer API

Get INTS split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/INTS

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 25.00 times fewer shares (a 1:25 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Intensity Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2026-02-191:25Yes$0.26$0.01

About Intensity Therapeutics, Inc.

Company overview and industry information

Intensity Therapeutics, Inc. (INTS) operates in the Biotechnology industry. The recent 1-for-25 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Intensity Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.